Psychiatric Annals, 2021;51(4):202–204
- 1.. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002; 53(1):547–554.
10.1016/S0022-3999(02)00443-9 PMID:12127170 > CrossrefGoogle Scholar - 2.. International Classification of Sleep Disorders. 3d ed. American Academy of Sleep Medicine; 2014. > Google Scholar
- 3.. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004; 5(3):237–246.
10.1016/j.sleep.2004.03.006 PMID:15165529 > CrossrefGoogle Scholar - 4.. Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity. Sleep Med. 2003; 4(2):133–135.
10.1016/S1389-9457(02)00193-4 PMID:14592343 > CrossrefGoogle Scholar - 5.. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2011; 24(4):422–428.
10.3122/jabfm.2011.04.100173 PMID:21737767 > CrossrefGoogle Scholar - 6.. Non-pharmacological interventions for restless legs syndrome: a systematic review of randomised controlled trials. Disabil Rehabil. 2019; 41(17):2006–2014.
10.1080/09638288.2018.1453875 PMID:29561180 > CrossrefGoogle Scholar - 7.. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006; 6(1):108–113.
10.1016/j.coph.2005.11.003 > CrossrefGoogle Scholar - 8.. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol. 2002; 249(2):164–170.
10.1007/PL00007859 PMID:11985381 > CrossrefGoogle Scholar - 9.. A double-blind, randomized, placebo-controlled exploratory study of SYN118 in restless legs syndrome. Mov Disord. 2011; 26(suppl 2):S363.
10.1002/mds.23764 > CrossrefGoogle Scholar - 10.. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006; 67(1):125–130.
10.1002/mds.23764 . PMID:16832090 > CrossrefGoogle Scholar - 11.. The association of restless legs syndrome with hypertension and cardiovascular disease. Med Sci Monit. 2014; 20:654–659.
10.12659/MSM.890252 PMID:24747872 > CrossrefGoogle Scholar - 12.. Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects. Expert Opin Drug Metab Toxicol. 2016; 12(9):1035–1045.
10.1080/17425255.2016.1198320 PMID:27310338 > CrossrefGoogle Scholar - 13.. Prevalence of restless legs syndrome during detoxification from alcohol and opioids. J Subst Abuse Treat. 2017; 73(73):35–39.
10.1016/j.jsat.2016.10.001 PMID:28017182 > CrossrefGoogle Scholar - 14.. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005; 28(7):891–898. PMID:
16124671 > Google Scholar
